Adverse Court Ruling Not To Affect Finisar’s Valuations (FNSR, DTV)
Paul Bonenfant, analyst at Morgan Keegan, believes that most investors have factored in an adverse ruling and never expected Finisar obtaining a monetary reward from this case. Morgan Keegan continues to maintain its target for Finisar at $14 per share.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.